approval · primary record
FOSTAMATINIB DISODIUM
FDA · NDA · 2025-02-04
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-02-04 |
| Brand | TAVALISSE |
| Sponsor | RIGEL PHARMS |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:41.876Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:FOSTAMATINIB DISODIUM:2025-02-04
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.